Process Research News Today

HARMONi and HARMONi-3 Enrollment Continues Promising Intracranial Anti-Tumor Activity and Safety Data Featured at the 2024 European Lung Cancer Congress with Ivonescimab Alone or Combined with...

2023 UK Annual Report 2023 UK Annual Report DEFINITIONS In this LivaNova PLC 2023 UK Annual Report, the...

2022 includes $15,500 in licensing revenue recognized in connection with an amendment of our License Agreement with Santen, effective March 31, 2022, net of a $500 transaction fee expense classified... -Today at 06:51 am- MarketScreener

"Browse 244 market data Tables and 42 Figures spread through 283 Pages and in-depth TOC on "Bioplastics & Biopolymers Market""The Bioplastics & Biopolymers Market witnesses strong growth globally, driven by increasing

On April 4, 2023, the National Labor Relations Board signaled that it might allow employees to recover damages stemming from employers refusing to follow bargaining orders pending appeal.

On April 4, 2023, the National Labor Relations Board signaled that it might allow employees to recover damages stemming from employers refusing to follow bargaining orders pending...

LONDON, April 5, 2023 SCI Canada Award 2023 dinner, seminar and presentations to take place on 18th April in Toronto Seminar theme is 'Unlocking the potential of Science Talent

/PRNewswire/ -- The best of Canadas scientific talent will debate its role in boosting economic growth at a special awards event on 18th April in Toronto....

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes appearing elsewhere in this Annual... | March 23, 2023

Starting in 2023, Celyad Oncology is now entirely focused on its new business strategy with one clear objective: help to overcome the current limitations of CAR-T approaches. It plans to do this via ... | March 23, 2023